|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.74 CNY | +2.11% |
|
+4.36% | -17.21% |
| Apr. 26 | BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 15 | BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
BGI Genomics Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 953.75 million compared to CNY 1,430.14 million a year ago. Revenue was CNY 953.75 million compared to CNY 1,430.14 million a year ago.
Net income was CNY 41.35 million compared to CNY 330.42 million a year ago. Basic earnings per share from continuing operations was CNY 0.0911 compared to CNY 0.805 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.21% | 2.08B | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M | |
| +13.32% | 332M |
BGI GENOMICS CO., LTD. 
